September 22, 2023 | The Recorder
A Light at the End of the Tunnel: Rebounding Biotech Transactions Provide Hope for Life Sciences CompaniesThe broader biotechnology equity capital markets have rebounded from their more recent lows in June 2022, according to Sidley Austin's Frank Rahmani, Istvan Hajdu and Carlton Fleming.
By Frank Rahmani, Istvan Hajdu and Carlton Fleming
7 minute read
Trending Stories